PreMD’s Prevu skin cholesterol test will be used in conjunction with one of the cosmetic company’s skin care products in a European clinical study. This follows an earlier successful study completed by PreMD with the cosmetic company.
Brent Norton, president and CEO of PreMD, said: “This is a very positive development for PreMD. To engage in collaborations with one of the world’s leading cosmetics conglomerates is a significant development which validates our expertise in skin testing, exposes our products’ capabilities to new markets, and opens the door to further commercial partnerships.
“We are excited by the prospect of developing new uses for the product in the cosmetics field and we are hoping to capitalize on these and other opportunities in the near future.”